Allert, Niels
Lindlau, Alexandra
Quindt, Regina
Reker, Paul
Timmermann, Lars
Barbe, Michael Thomas
Article History
Received: 4 June 2018
Accepted: 13 August 2018
First Online: 17 August 2018
Compliance with ethical standards
: The patient has consented to submission of this case report to the journal.
: Niels Allert has received honoraria from Medtronic for lecturing and consulting. Alexandra Lindlau and Regina Quindt have nothing to disclose. Paul Reker received a travel grant from AbbVie. Between September 2014 and September 2017 Lars Timmermann received payments as a consultant for Medtronic Inc., Boston Scientific, GE Medical, UCB Schwarz Pharma. Lars Timmermann also received honoraria as a speaker on symposia sponsored by Bial, Zambon Pharma, UCB Schwarz Pharma, Desitin Pharma, Medtronic, Boston Scientific, Abott, Bayer. The institution of Lars Timmermann, not Lars Timmermann personally received funding by the German Research Foundation, the German Ministry of Education and Research, Manfred und Ursula Müller Stiftung, Klüh Stiftung, Hoffnungsbaum e. V., NBIA DISORDERS SOCIETY USA, Köln Fortune, Medtronic, Deutsche Parkinson Vereinigung. Archimedes Pharma, Abott, Bayer, UCB, zur Rose Pharma, TEVA. Neither Lars Timmermann nor any member of his family holds stocks, stock options, patents or financial interests in any of the abovementioned companies or their competitors. Michael T Barbe has received speaker’s honoraria from Medtronic, St. Jude, UCB and GE Medical as well as research grants from Medtronic.